127 related articles for article (PubMed ID: 15303374)
1. Effects of phenylhydrazine or recombinant human erythropoietin on deformability and activity of dehydrogenase glucose-6-phosphate and acetylcholinesterase in Wistar rats blood enriched in reticulocytes.
Nowak E; Wyrwicz G; Dabrowski Z; Smoleński O; Spodaryk K
Folia Biol (Krakow); 2003; 51(3-4):195-9. PubMed ID: 15303374
[TBL] [Abstract][Full Text] [Related]
2. Priming dose of phenylhydrazine protects against hemolytic and lethal effects of 2-butoxyethanol.
Palkar PS; Philip BK; Reddy RN; Mehendale HM
Toxicol Appl Pharmacol; 2007 Nov; 225(1):102-12. PubMed ID: 17850838
[TBL] [Abstract][Full Text] [Related]
3. Deformability and enzymes activities of red blood cells in hemodialysed and peritoneal dialysed patients with chronic renal disease.
Nowak-Piszczek E; Wyrwicz G; Dabrowski Z; Smoleński O; Spodaryk K
Clin Hemorheol Microcirc; 2003; 28(4):251-7. PubMed ID: 12897415
[TBL] [Abstract][Full Text] [Related]
4. Energy production and redox status of rat red blood cells after reticulocytosis induced by various treatments.
Marković SD; Zižić JB; Obradović AD; Ognjanović BI; Stajn AS; Saičić ZS; Spasić MB
Acta Biol Hung; 2011 Jun; 62(2):122-32. PubMed ID: 21555264
[TBL] [Abstract][Full Text] [Related]
5. Phenylhydrazine as a partial model for beta-thalassaemia red blood cell hemodynamic properties.
Ramot Y; Koshkaryev A; Goldfarb A; Yedgar S; Barshtein G
Br J Haematol; 2008 Mar; 140(6):692-700. PubMed ID: 18302715
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats.
Woo S; Krzyzanski W; Jusko WJ
J Pharmacol Exp Ther; 2006 Dec; 319(3):1297-306. PubMed ID: 16973883
[TBL] [Abstract][Full Text] [Related]
7. The role of thyroid hormone on phenylhydrazine hydrochloride mediated inhibitory effects on blood acetylcholinesterase: an in vivo and in vitro study.
Banerjee M; Ray AK
J Biochem Mol Toxicol; 2002; 16(4):162-8. PubMed ID: 12242684
[TBL] [Abstract][Full Text] [Related]
8. Rheological and biochemical examination of red blood cells after treatment with different pharmacological and toxic substances.
Nowak E; Wyrwicz G; Dabrowski Z; Smolenski O; Spodaryk K
Clin Hemorheol Microcirc; 2002; 26(2):91-7. PubMed ID: 12082257
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals.
Gurbuz N; Yalcin O; Aksu TA; Baskurt OK
Clin Hemorheol Microcirc; 2004; 31(3):235-42. PubMed ID: 15322329
[TBL] [Abstract][Full Text] [Related]
10. Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin.
Woo S; Jusko WJ
Drug Metab Dispos; 2007 Sep; 35(9):1672-8. PubMed ID: 17576810
[TBL] [Abstract][Full Text] [Related]
11. Membrane alterations in phenylhydrazine-induced reticulocytes.
Jain SK; Hochstein P
Arch Biochem Biophys; 1980 May; 201(2):683-7. PubMed ID: 7396527
[No Abstract] [Full Text] [Related]
12. [On the biophysics characteristics of reticulocytes].
Xie L; Yang H; Sun D; Wen Z; Tan W
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):392-5. PubMed ID: 16706374
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.
Ramakrishnan R; Cheung WK; Wacholtz MC; Minton N; Jusko WJ
J Clin Pharmacol; 2004 Sep; 44(9):991-1002. PubMed ID: 15317827
[TBL] [Abstract][Full Text] [Related]
14. A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport?
Borrione P; Parisi A; Salvo RA; Spaccamiglio A; Pautasso M; Baraban D; Piccoli GB; Pigozzi F; Angeli A
J Biol Regul Homeost Agents; 2007; 21(3-4):79-88. PubMed ID: 18261259
[TBL] [Abstract][Full Text] [Related]
15. Effects of phenylhydrazine or phlebotomy on peripheral blood, bone marrow and erythropoietin in Wistar rats.
Criswell KA; Sulkanen AP; Hochbaum AF; Bleavins MR
J Appl Toxicol; 2000; 20(1):25-34. PubMed ID: 10641014
[TBL] [Abstract][Full Text] [Related]
16. Impaired erythrocytes deformability in H(2)O(2)-induced oxidative stress: protective effect of L-carnosine.
Aydogan S; Yapislar H; Artis S; Aydogan B
Clin Hemorheol Microcirc; 2008; 39(1-4):93-8. PubMed ID: 18503115
[TBL] [Abstract][Full Text] [Related]
17. Activity of reticulocyte and erythrocyte acetylcholinesterase of rats in normal and experimental conditions.
Spodaryk K; Dabrowski Z; Miszta H; Szyguła Z
Folia Biol (Krakow); 1986; 34(3):313-7. PubMed ID: 3817218
[No Abstract] [Full Text] [Related]
18. [Properties of glucose-6-phosphate dehydrogenase of young reticulocytes and erythrocytes in humans and rabbits].
Fornaini G; Segni P; Leoncini G; Balduini C; Calabria GA
Boll Soc Ital Biol Sper; 1967 Nov; 43(22):1504-7. PubMed ID: 4386078
[No Abstract] [Full Text] [Related]
19. Circadian variations in the activities of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in the liver of control and streptozotocin-induced diabetic rats.
Ulusu NN; Ozbey G; Tandogan B; Gunes A; Durakoglugil DB; Karasu C; Uluoglu C; Zengil H
Chronobiol Int; 2005; 22(4):667-77. PubMed ID: 16147898
[TBL] [Abstract][Full Text] [Related]
20. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
